Mostrando 3 resultados de: 3
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
ArticleAbstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emergent pathogen responsible forPalabras claves:Autores:Azevedo-Quintanilha I.G., Barreto E.A., Bozza F.A., Bozza P.T., Franco S., Hottz E.D., Palhinha L., Pão C.R.R., Pedro M.P. Kurtz, Righy C., Souza T.M.L., Teixeira L.Fuentes:scopusThe Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Development of Case Report Forms for Global Use
ArticleAbstract: Since its original report in January 2020, the coronavirus disease 2019 (COVID-19) due to Severe AcuPalabras claves:Case report form, Common data element, CORONAVIRUS, covid-19, Disease prevalence, Neurological manifestations, Neurological symptoms, SARS-COV2Autores:Altamirano V., Chou S.H.Y., Fink E.L., Frontera J.A., Helbok R., Mainali S., McNett M., Mejia-Mantilla J.H., Menon D.K., Nelson J. Maldonado, Pedro M.P. Kurtz, Righy C., Roa J.D., Robertson C.L., Schober M.E., Suarez J.I., Villamizar-Rosales C.Fuentes:scopusThrombotic and Hemorrhagic Neurological Complications in Critically Ill COVID-19 Patients
ArticleAbstract:Palabras claves:Autores:Gonçalves B., Pedro M.P. Kurtz, Righy C.Fuentes:scopus